Hematological Tumor Global Clinical Trials Review, H2, 2017

2017-09-01
Price :
Published : Sep-2017
No. of Pages : 247
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
GlobalData Clinical Trials Report Coverage 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by G7 Countries: Proportion of Hematological Tumor to Oncology Clinical Trials 16
Clinical Trials by Phase in G7 Countries 17
Clinical Trials in G7 Countries by Trial Status 18
Clinical Trials by E7 Countries: Proportion of Hematological Tumor to Oncology Clinical Trials 19
Clinical Trials by Phase in E7 Countries 20
Clinical Trials in E7 Countries by Trial Status 21
Clinical Trials by Phase 22
In Progress Trials by Phase 23
Clinical Trials by Trial Status 24
Clinical Trials by End Point Status 25
Subjects Recruited Over a Period of Time 26
Clinical Trials by Sponsor Type 27
Prominent Sponsors 28
Top Companies Participating in Hematological Tumor Therapeutics Clinical Trials 29
Prominent Drugs 30
Latest Clinical Trials News on Hematological Tumor 31
Aug 23, 2017: ImmunoCellular Therapeutics Provides Business Update on Research and Development Programs and Future Strategy 31
Jun 23, 2017: Bellicum Announces Clinical Data on BPX-501 at Presidential Symposium of the 22nd Congress of the European Hematology Association 31
Clinical Trial Profile Snapshots 33
Appendix 244
Abbreviations 244
Definitions 244
Research Methodology 245
Secondary Research 245
About GlobalData 246
Contact Us 246
Disclaimer 246
Source 247

List of Tables
Hematological Tumor Therapeutics, Global, Clinical Trials by Region, 2017* 7
Hematological Tumor Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 9
Hematological Tumor Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 10
Hematological Tumor Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2017* 11
Hematological Tumor Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 12
Hematological Tumor Therapeutics Clinical Trials, North America, Top Countries, 2017* 13
Hematological Tumor Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2017* 14
Hematological Tumor Therapeutics Clinical Trials, Central and South America, Top Countries, 2017* 15
Proportion of Hematological Tumor to Oncology Clinical Trials, G7 Countries (%), 2017* 16
Hematological Tumor Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 17
Hematological Tumor Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 18
Proportion of Hematological Tumor to Oncology Clinical Trials, E7 Countries (%), 2017* 19
Hematological Tumor Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 20
Hematological Tumor Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 21
Hematological Tumor Therapeutics, Global, Clinical Trials by Phase, 2017* 22
Hematological Tumor Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 23
Hematological Tumor Therapeutics, Global, Clinical Trials by Trial Status, 2017* 24
Hematological Tumor Therapeutics Clinical Trials, Global, by End Point Status, 2017* 25
Hematological Tumor Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 26
Hematological Tumor Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 27
Hematological Tumor Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 28
Hematological Tumor Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 29
Hematological Tumor Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 30

List of Figures
Hematological Tumor Therapeutics, Global, Clinical Trials by Region (%), 2017* 7
Hematological Tumor Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 8
Hematological Tumor Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 10
Hematological Tumor Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2017* 11
Hematological Tumor Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017* 12
Hematological Tumor Therapeutics Clinical Trials, North America, Top Countries (%), 2017* 13
Hematological Tumor Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2017* 14
Hematological Tumor Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2017* 15
Proportion of Hematological Tumor to Oncology Clinical Trials, G7 Countries (%), 2017* 16
Hematological Tumor Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 17
Hematological Tumor Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 18
Proportion of Hematological Tumor to Oncology Clinical Trials, E7 Countries (%), 2017* 19
Hematological Tumor Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 20
Hematological Tumor Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 21
Hematological Tumor Therapeutics, Global, Clinical Trials by Phase (%), 2017* 22
Hematological Tumor Therapeutics, Global, Clinical Trials In Progress by Phase, 2017* 23
Hematological Tumor Therapeutics, Global, Clinical Trials by Trial Status, 2017* 24
Hematological Tumor Therapeutics Clinical Trials, Global, by End Point Status, 2017* 25
Hematological Tumor Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 26
Hematological Tumor Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 27
Hematological Tumor Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 28
Hematological Tumor Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 29
Hematological Tumor Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 30
GlobalData Methodology 245
Filed in: Pharmaceutical, Pharmaceuticals and Healthcare
Publisher : GlobalData